AptarGroup, Inc. (ATR)
- Previous Close
145.92 - Open
147.11 - Bid 143.33 x 800
- Ask 157.00 x 800
- Day's Range
144.84 - 147.13 - 52 Week Range
111.63 - 148.51 - Volume
259,951 - Avg. Volume
330,129 - Market Cap (intraday)
9.728B - Beta (5Y Monthly) 0.58
- PE Ratio (TTM)
31.57 - EPS (TTM)
4.65 - Earnings Date Jul 25, 2024
- Forward Dividend & Yield 1.64 (1.12%)
- Ex-Dividend Date Apr 24, 2024
- 1y Target Est
146.33
AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; and active material science solutions. In addition, the company offers dispensing pumps, closures, elastomeric components, and aerosol valves to the digital health solutions. It primarily sells its products and services in Asia, Europe, Latin America, and North America. AptarGroup, Inc. was incorporated in 1992 and is headquartered in Crystal Lake, Illinois.
www.aptar.com13,000
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: ATR
Performance Overview: ATR
Trailing total returns as of 5/3/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ATR
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ATR
Valuation Measures
Market Cap
9.73B
Enterprise Value
10.69B
Trailing P/E
31.50
Forward P/E
28.09
PEG Ratio (5yr expected)
3.37
Price/Sales (ttm)
2.78
Price/Book (mrq)
4.14
Enterprise Value/Revenue
3.02
Enterprise Value/EBITDA
15.27
Financial Highlights
Profitability and Income Statement
Profit Margin
8.83%
Return on Assets (ttm)
6.74%
Return on Equity (ttm)
13.92%
Revenue (ttm)
3.54B
Net Income Avi to Common (ttm)
312.83M
Diluted EPS (ttm)
4.65
Balance Sheet and Cash Flow
Total Cash (mrq)
201.06M
Total Debt/Equity (mrq)
49.84%
Levered Free Cash Flow (ttm)
190.92M
Research Analysis: ATR
Company Insights: ATR
ATR does not have Company Insights